Plain-English translation of NCT06564818 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Major Depressive Disorder research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called to see if it can help people with moderate to severe depression who haven't improved enough with their current antidepressant alone. You would continue taking your regular antidepressant while also receiving the new treatment. The study will compare how well this medication works compared to a placebo (an inactive pill that looks identical).
Many people with depression don't get complete relief from their current medications alone. Researchers are testing this new treatment to see if it could help those whose symptoms remain difficult to manage despite being on an adequate dose of antidepressant.
You likely qualify if…
You likely don't qualify if…
You would visit the study site twice, about three weeks apart, to receive either the new medication or a placebo pill. Throughout the trial, you'll continue taking your regular antidepressant and receive psychological support. The study team will monitor your symptoms and how you're responding to the treatment, and you'll complete assessments to measure changes in your depression.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
United States